Stock Blog Hub » CAH

(CAH) Cardinal Health Analyst Maintains Outperform on Shares

vitalstocks — Wed, 07 Dec 2011 17:53:10 +0000

We reiterate our Outperform rating on Cardinal Health (CAH). Its first-quarter fiscal 2012 (ended September 30) adjusted earnings per share of 73 cents beat the Zacks Consensus Estimate of 72 cents. Earnings from continuing operations (as reported) dropped about 19% year over year reflecting a previous-year gain from the sale of CareFusion (CFN) shares. Sales [...]

(CAH) Cardinal Health Analyst Maintains Outperform on Shares

(OMCL) Omnicell Beats Estimates

vitalstocks — Fri, 04 Nov 2011 18:57:59 +0000

Omnicell Inc. (OMCL) reported EPS of 9 cents during the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate of 8 cents and the year-ago quarter EPS of 4 cents. Reported earnings shot up 125% on a year-over-year basis primarily due to the reduction in effective tax rate from 60% in the year-ago [...]

(OMCL) Omnicell Beats Estimates

(CAH) Cardinal Health Incorporated – Bull of the Day

vitalstocks — Fri, 07 Oct 2011 16:27:17 +0000

We recently upgraded our rating on Cardinal Health, Inc. (CAH) to Outperform. Earnings for the fourth quarter narrowly beat the Zacks Consensus Estimate. Cardinal’s size and diversity partly insulate it from economic cycles, and its generics business continues to grow at a healthy pace. Moreover, Cardinal’s Pharmaceutical and Medical segments have revamped operations. The company [...]

(CAH) Cardinal Health Incorporated – Bull of the Day

vitalstocks — Mon, 03 Oct 2011 19:20:00 +0000

We upgrade our rating on Cardinal Health, Inc. (CAH) to Outperform. Earnings for the fourth quarter narrowly beat the Zacks Consensus Estimate. Cardinal’s size and diversity partly insulate it from economic cycles. Its generics business continues to grow at a healthy pace. Moreover, Cardinal’s Pharmaceutical and Medical segments have revamped operations. The company continues to [...]

(CAH) Cardinal Health Incorporated – Bull of the Day

(OMCL) Omnicell Analyst Maintains Neutral on Shares

vitalstocks — Tue, 20 Sep 2011 20:17:32 +0000

We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $16.00. Omnicell reported an adjusted EPS of 8 cents in the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate and the year-ago quarter’s EPS of 6 cents. Total revenue for the second quarter was $61.0 million, up 6.6% [...]

(OMCL) Omnicell Analyst Maintains Neutral on Shares

(WAG) Walgreen in Elite League

vitalstocks — Tue, 20 Sep 2011 20:05:51 +0000

Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 Information Week 500. The company added another feather in its cap when it became the top-ranked company in the retail and general merchandising category. The company considers both the achievements as huge recognition for its innovative [...]

(WAG) Walgreen in Elite League

(WAG) Walgreen Ranked as Technology Innovator

vitalstocks — Thu, 15 Sep 2011 18:08:51 +0000

Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 InformationWeek 500. The company added another feather in its cap when it became the top-ranked company in the retail and general merchandising category. The company considers both the achievements as huge recognition for its innovative technology [...]

(WAG) Walgreen Ranked as Technology Innovator

(ABC) AmerisourceBergen Analyst Reiterates Neutral on Shares

vitalstocks — Fri, 26 Aug 2011 22:29:09 +0000

We recently reiterated our Neutral recommendation on AmerisourceBergen Corporation (ABC) with a target price of $40.00. Over the last several years, the company has been benefiting from the growth of the pharmaceutical industry in the US. We believe AmerisourceBergen should continue to benefit from growth in the pharmaceutical industry, which is driven by several factors [...]

(ABC) AmerisourceBergen Analyst Reiterates Neutral on Shares

(OMCL) Omnicell’s Electronic Health Record Wins Certification

vitalstocks — Wed, 22 Jun 2011 17:01:42 +0000

Omnicell, Inc. (OMCL), a leading developer and marketer of end-to-end automation solutions for the medication-use process, recently announced that its newly launched G4 platform received the ONC-ATCB certification as a Modular Electronic Health Record (“EHR”). Omnicell became the first hospital pharmacy automation company to achieve this certification and the company intends to support its clients [...]

(OMCL) Omnicell’s Electronic Health Record Wins Certification

(OMCL) Omnicell Earns Second Consecutive Best in Klas Award

vitalstocks — Sun, 19 Jun 2011 17:33:41 +0000

Omnicell (OMCL), recently announced that it has received recognition for its OmniRx automated dispensing system from leading research firm, KLAS for the second consecutive year. Along with the 2011 “Best in KLAS” award for Automated Medication Dispensing Units for large hospitals with more than 200 beds category, Omnicell was also recognized as the Category Leader [...]

(OMCL) Omnicell Earns Second Consecutive Best in Klas Award

(CAH) Cardinal Health Third Quarter 2011 Earnings Preview

vitalstocks — Wed, 27 Apr 2011 17:28:55 +0000

Cardinal Health (CAH) is slated to report its third-quarter fiscal 2011 (ending March) results on Thursday, April 28. The company expects earnings per share in the range of $2.54 to $2.60 for fiscal 2011. The current Zacks Consensus Estimate for revenues and earnings for the third quarter are $25.6 billion and 69 cents per share, [...]

(CAH) Cardinal Health Third Quarter 2011 Earnings Preview

(WPI) Watson Pharmaceuticals Analyst Maintains Neutral Rating on Shares

vitalstocks — Thu, 17 Mar 2011 17:02:54 +0000

We recently reaffirmed our Neutral stance on Watson Pharmaceuticals Inc. (WPI) following the release of fourth quarter and fiscal year 2010 financial results. Quarterly earnings of 93 cents per share were in line with the Zacks Consensus Estimate and 8 cents above the year-ago earnings. Revenues increased 21.2% to $952.7 million, mainly due to the [...]

(WPI) Watson Pharmaceuticals Analyst Maintains Neutral Rating on Shares

(CAH) Cardinal Health Gets Antitrust Clearance

vitalstocks — Mon, 20 Dec 2010 20:27:38 +0000

Cardinal Health (CAH) recently announced that antitrust regulators had cleared its $1.3 billion takeover of Kinray, a leading pharma distributor with a presence in the New York metropolitan area. In this regard, the Federal Trade Commission (“FTC”) had approved early termination of waiting period, under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, for the planned [...]

(CAH) Cardinal Health Gets Antitrust Clearance

(CAH) Cardinal Health Announces Buy of Kinray

vitalstocks — Sun, 19 Dec 2010 23:25:20 +0000

Cardinal Health (CAH) recently announced plans to purchase Kinray Inc., a leading pharma distributor with a presence in the New York metropolitan area. The cash deal will enhance Cardinal’s capability to cater to retail independent pharmacies in the northeastern U.S. markets. Cardinal expects to close the deal by the end of the current calendar year, [...]

(CAH) Cardinal Health Announces Buy of Kinray

(CAH) Cardinal Health Prepares for Coming Flu Season

vitalstocks — Mon, 04 Oct 2010 05:13:42 +0000

Cardinal Health (CAH) is taking necessary steps to maintain the supply of influenza vaccines during the forthcoming 2010-2011 flu season. For the first time, the Advisory Committee on Immunization Practices (ACIP) has been asking everyone over 6 months of age to get a flu vaccine. The company is of the opinion that the supplies are [...]

(CAH) Cardinal Health Prepares for Coming Flu Season

(CAH) Cardinal Health Sells Remaining CareFusion Shares

vitalstocks — Sun, 19 Sep 2010 17:57:49 +0000

Cardinal Health (CAH), a leading distributor of pharmaceuticals and medical supplies, recently sold off the remaining 30.5 million shares of CareFusion Corporation (CFN) for $705.9 million. CareFusion, a San Diego-based vendor for medical equipment and infection control supplies, was spun off from Cardinal Health in 2009. As per the spin-off arrangement, Cardinal Health distributed 0.5 [...]

(CAH) Cardinal Health Sells Remaining CareFusion Shares

(CAH) Cardinal Health and Cumberland Pharmaceuticals Sign Deal

vitalstocks — Sun, 22 Aug 2010 23:15:27 +0000

Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, has reportedly inked a distribution agreement with Nashville, Tennessee-based Cumberland Pharmaceuticals (CPIX), a specialty pharmaceutical firm focused on the acute-care hospital and gastroenterology markets. Financial terms of the deal were not divulged by the companies. Under the three-year deal, Cardinal will exclusively [...]

(CAH) Cardinal Health and Cumberland Pharmaceuticals Sign Deal

vitalstocks — Wed, 18 Aug 2010 18:32:48 +0000

(CAH) Cardinal Health and Cumberland Pharmaceuticals Sign Deal

(CAH) Cardinal Health Earnings Scorecard

vitalstocks — Thu, 12 Aug 2010 05:16:19 +0000

Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, recently reported earnings for fourth-quarter of fiscal year 2010, which beat the Zacks Consensus Estimate by a penny. Revenues grew by a mere 0.5% year over year to $22.3 billion. Pharmaceutical revenues were essentially flat year over year as higher sales to [...]

(CAH) Cardinal Health Earnings Scorecard

(CAH) Cardinal Health Analyst Reaffirms Neutral Rating

vitalstocks — Wed, 11 Aug 2010 01:34:51 +0000

We maintain our Neutral recommendation for Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies. Earnings for fourth-quarter fiscal 2010 beat the Zacks Consensus Estimate by a penny. However, profit dipped year-over-year, impacted by the spin-off of the company’s non-core Clinical and Medical Products segment (CareFusion), lower customer pricing and supply [...]

(CAH) Cardinal Health Analyst Reaffirms Neutral Rating

(CAH) Cardinal Health’s Report Beats Expectations by a Penny

vitalstocks — Fri, 06 Aug 2010 16:56:23 +0000

Cardinal Health (CAH) reported fourth-quarter and fiscal 2010 adjusted (excluding one-time expenses) earnings per share of 50 cents and $2.22 respectively, exceeding the Zacks Consensus Estimates of 49 cents and $2.21, respectively, but below the year-ago results of 63 cents and $2.26, respectively. Revenues Total revenue was $24.5 billion in the fourth quarter, up by [...]

(CAH) Cardinal Health’s Report Beats Expectations by a Penny

(CAH) Cardinal Health – Increased Dividend by 11%

vitalstocks — Fri, 06 Aug 2010 16:49:50 +0000

Cardinal Health (CAH) is in a stable industry with steady revenues and a safe dividend. Growth and Income The company is expected to grow its EPS 10.8% over the next three to five years. The stock also offers investors a dividend yield of 2.3%. This Zacks #2 Rank stock trades at 13.4x fiscal year 2011 [...]

(CAH) Cardinal Health – Increased Dividend by 11%

(CAH) Cardinal Health Earnings Preview

vitalstocks — Tue, 03 Aug 2010 04:23:56 +0000

Cardinal Health (CAH) is slated to report fourth-quarter and fiscal 2010 (ending June 30, 2010) results on Thursday, August 5, 2010. The company earlier issued earnings per share guidance in the range of $2.15 to $2.20 for fiscal 2010. The current Zacks Consensus Estimate for the fourth quarter is 49 cents, representing an estimated 43.2% [...]

(CAH) Cardinal Health Earnings Preview

(CAH) Cardinal Health Quarterly Earnings Outperform

vitalstocks — Fri, 30 Apr 2010 15:52:30 +0000

Cardinal Health, Inc. (CAH) reported third quarter fiscal 2010 earnings per share of 61 cents, outperforming the Zacks Consensus Estimate of 57 cents. However, earnings were lower than the year-ago figure of 66 cents. Sales Total sales in the third quarter increased 1% year over year to $24.3 billion. Growth was witnessed across all business [...]

(CAH) Cardinal Health Quarterly Earnings Outperform

(ABC) AmerisourceBergen Beats Forecasts – Raises Outlook Again

vitalstocks — Thu, 22 Apr 2010 21:32:51 +0000

AmerisourceBergen Corp. (ABC) posted second quarter fiscal 2010 earnings of 63 cents per share, beating the Zacks Consensus Estimate by 8 cents. Earnings increased 34% from the year-ago period. Performance was driven by strong revenues, successful generic drug launches, and continued expense management. Total revenues for the quarter increased 11.5% to $19.3 billion. This was [...]

(ABC) AmerisourceBergen Beats Forecasts – Raises Outlook Again

(CFN) CareFusion Decides to Acquire Medegen for $225 Million

vitalstocks — Thu, 08 Apr 2010 00:24:51 +0000

CareFusion Corporation (CFN) has decided to acquire Medegen for $225 million in cash. CareFusion expects the acquisition to be neutral to the adjusted earnings per share in the first year of operations and increasingly accretive thereafter. The acquisition is expected to be completed by June 30, 2010. Medegen is a leading innovator in infusion therapy [...]

(CFN) CareFusion Decides to Acquire Medegen for $225 Million

(PBR) U.S. Consumer Price Index Remains Tame

vitalstocks — Thu, 18 Mar 2010 20:26:45 +0000

We got more evidence today that inflation is not a serious concern. The Consumer Price Index (CPI) was unchanged in February after five straight months when it had increased by only 0.2% per month. Overall consumer prices are just 2.1% higher than a year ago. If food and energy prices are stripped out to get [...]

(PBR) U.S. Consumer Price Index Remains Tame

(CAH) Cardinal Health – Earnings Estimates Are Moving Higher

vitalstocks — Wed, 03 Mar 2010 23:51:16 +0000

Cardinal Health (CAH) provides investors with 10% earnings growth and a dividend yield of 2%. Company Description Cardinal Health is one of the largest distributors of pharmaceuticals and medical supplies. The company is also a leading provider of products and services that improve the safety and productivity of health-care providers. Cardinal Health manufactures medication infusion [...]

(CAH) Cardinal Health – Earnings Estimates Are Moving Higher

(CFN) CareFusion Corporation Beats Consensus Estimates

vitalstocks — Thu, 11 Feb 2010 00:21:08 +0000

CareFusion Corporation (CFN) recently reported second quarter fiscal 2010 earnings per share of 39 cents, marginally beating the Zacks Consensus Estimate of 38 cents, but lower than the year-ago earnings of 50 cents. Total revenues in the second quarter increased 5% year over year to $1.0 billion. Growth was witnessed across all business segments. Critical [...]

(CFN) CareFusion Corporation Beats Consensus Estimates

(CAH) Cardinal Health Upgraded to Outperform

vitalstocks — Wed, 10 Feb 2010 21:17:07 +0000

We have recently upgraded Cardinal Health Inc. (CAH) to “Outperform” with a target price of $37 based on approximately 15.7x our fiscal 2011 EPS estimate of $2.36. Cardinal Health reported second quarter fiscal 2010 earnings per share of 57 cents, beating the Zacks Consensus Estimate of 46 cents and the year-ago earnings of 51 cents. [...]

(CAH) Cardinal Health Upgraded to Outperform

(CAH) Cardinal Health Beats Expectations and Boosts Estimates

vitalstocks — Thu, 28 Jan 2010 20:26:37 +0000

Cardinal Health, Inc. (CAH) reported second quarter fiscal 2010 earnings per share of 57 cents, surpassing the Zacks Consensus Estimate of 46 cents and the year-ago earnings of 51 cents. Sales Total sales in the reported quarter increased 3% year over year to $24.9 billion. Growth was witnessed across all business segments. Pharmaceutical segment revenues [...]

(CAH) Cardinal Health Beats Expectations and Boosts Estimates

(CFN) CareFusion Corporation Enters Agreement with Masimo

vitalstocks — Sat, 14 Nov 2009 22:12:01 +0000

CareFusion Corp. (CFN) entered into a multi-year technology licensing agreement with Masimo Corp. (MASI) regarding the use of Masimo Rainbow SET Pulse CO-Oximetry technology in CareFusion infusion and respiratory products, which are presently under development. The agreement enables CareFusion’s future infusion and respiratory products to non-invasively and continuously measure multiple blood constituents to more accurately [...]

(CFN) CareFusion Corporation Enters Agreement with Masimo

(CAH) Cardinal Health Eclipses Consensus Estimates

vitalstocks — Mon, 09 Nov 2009 03:29:25 +0000

Cardinal Health (CAH) reported fiscal first-quarter earnings per share of 54 cents, surpassing the Zacks Consensus Estimate of 43 cents and the year-ago earnings of 47 cents. Sales Total sales in the reported quarter increased 6% year over year to $24.8 billion. Growth was witnessed across all the business segments. Pharmaceutical segment revenues increased 5% [...]

(CAH) Cardinal Health Eclipses Consensus Estimates

(CAH) Cardinal Health Completes Spin-Off – Analyst Blog

vitalstocks — Thu, 03 Sep 2009 01:49:35 +0000

Cardinal Health, Inc. (CAH) has completed the spin-off of its Clinical and Medical Products business to form a subsidiary, CareFusion Corporation (CFN). The spin-off was completed through a pro rata distribution of roughly 81% of CareFusion’s common stock. Roughly 222 million shares of CareFusion common stock were outstanding on the date of distribution. Of this, [...]

(CAH) Cardinal Health Completes Spin-Off – Analyst Blog

(CAH) Cardinal Health Makes Buyback Offer

vitalstocks — Sat, 29 Aug 2009 00:08:04 +0000

Cardinal Health, Inc. (CAH) has offered to buy back $1.2 billion of its long-term debt securities (notes) as part of its plan to reduce long-term debt after spinning off its CareFusion Corporation division on Aug 31, 2009. These securities carry maturity dates from 2011 to 2026. The offer expires on Sept. 24 and the owners [...]

(CAH) Cardinal Health Makes Buyback Offer

(CAH) Cardinal Health Sees Positive Results for Skin Preparation Drug

vitalstocks — Thu, 27 Aug 2009 18:57:42 +0000

Cardinal Health Inc. (CAH) announced that the use of the preoperative skin preparation, ChloraPrep, is significantly more effective than both DuraPrep and povidone-iodine at eliminating overall bacteria from the shoulder region. After antisepsis with ChloraPrep, only 7% of skin cultures tested positive for bacteria compared to 19% for DuraPrep and 31% for povidone-iodine. The data [...]

(CAH) Cardinal Health Sees Positive Results for Skin Preparation Drug

(CAH) Cardinal’s Spin-off to be Added to S&P 500 Index

vitalstocks — Tue, 25 Aug 2009 20:22:32 +0000

Cardinal Health Inc. (CAH) announced that its spin-off subsidiary, CareFusion Corp., will be included in the S&P 500 after the close of trading on Aug 31. CareFusion replaces The Manitowoc Co. Inc. (MTW) in the index and will be added to the S&P 500 GICS (Global Industry Classification Standard) Health Care Equipment Sub-Industry index. CareFusion [...]

(CAH) Cardinal’s Spin-off to be Added to S&P 500 Index

(TSL) Investing in Crude Oil: The Best Way to Play Oil’s Imminent Rebound

InvestmentU — Tue, 10 Mar 2009 18:08:01 +0000

by Louis Basenese, Advisory Panelist Senior Analyst, The Oxford Club Billionaire investor George Soros and I don’t normally see eye to eye. He supports drug decriminalization, assisted suicide, America bashing… and a host of other off-the-reserve liberal causes. I don’t. I’m an old-school Reagan conservative. (Full disclosure – I’m so old school, I named my [...]

(TSL) Investing in Crude Oil: The Best Way to Play Oil’s Imminent Rebound

InvestmentU — Fri, 20 Feb 2009 03:54:25 +0000

(TSL) Investing in Crude Oil: The Best Way to Play Oil’s Imminent Rebound

(CAH) Cardinal Health, Inc.: Stock of the Day

InvestmentU — Tue, 17 Feb 2009 22:36:38 +0000

by David Fessler, Advisory Panelist, Investment U When we think of industrial suppliers, W.W. Grainger (NYSE:GWW) is one of the largest in the business. From nuts and bolts to janitorial supplies, it’s a good bet Grainger’s can supply it. The company consolidates parts, equipment and supplies from thousands of manufacturers and provides customers with one-stop [...]

(CAH) Cardinal Health, Inc.: Stock of the Day

(SNY) Healthcare Stocks…Are They Truly Recession-Proof?

InvestmentU — Fri, 23 Jan 2009 01:05:32 +0000

Healthcare Stocks…Are They Truly Recession-Proof? This past weekend, I was up at my hunting and fishing club in northeast Pennsylvania enjoying some ice fishing. At our club at least, it’s a pleasant social activity with great food, wine and stories shared among the members and spouses.This year, it happened to fall on the coldest day [...]

(SNY) Healthcare Stocks…Are They Truly Recession-Proof?